Share to Facebook Share to Twitter Bookmark and Share
File #: 231147    Version: 1 Name: Agreement Amendment - McKesson Plasma and Biologics LLC - Group Purchasing Organization Purchase of Pharmaceuticals - Not to Exceed $1,466,737,824
Type: Resolution Status: Passed
Introduced: 11/14/2023 In control: Clerk of the Board
On agenda: 11/14/2023 Final action: 12/19/2023
Enactment date: 12/19/2023 Enactment #: 587-23
Title: Resolution approving Amendment No. 1 to the Group Purchasing Organization (GPO) pharmaceutical Agreement between McKesson Plasma and Biologics LLC and the Department of Public Health (DPH), under Administrative Code, Chapter 21A.2, to increase the Agreement amount by $1,170,803,034 for a not to exceed amount of $1,466,737,824; extend the term by four years and five months from February 1, 2024, for a total term of February 1, 2020, through June 30, 2028; and authorize DPH to enter into modifications of the Agreement that do not materially increase the City’s obligations or liabilities and are necessary to effectuate the purposes of the Agreement or this Resolution.
Attachments: 1. Leg Ver1, 2. DRAFT Amend No. 1, 3. Original Agreement 110119, 4. BOS Reso No. 124-20 032420, 5. DPH Ltr 103023, 6. Form 126, 7. DPH Presentation 120623, 8. BLA Rpt 120623, 9. Cmte Pkt 120623, 10. Board Pkt 121223, 11. Form 126 Final, 12. Leg Final
Related files: 200013
Legislation Details
 *NOTE: These reports are produced in HTML format and are accessible to screen readers.